Latest Insider Transactions at Orthopediatrics Corp (KIDS)
This section provides a real-time view of insider transactions for Orthopediatrics Corp (KIDS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ORTHOPEDIATRICS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ORTHOPEDIATRICS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 11
2021
|
David R Pelizzon Director |
BUY
Open market or private purchase
|
Direct |
825
+3.44%
|
$54,450
$66.48 P/Share
|
|
Nov 02
2021
|
Bernie B Berry Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,119
+7.29%
|
-
|
|
Sep 07
2021
|
(Reynolds) Marie C Infante Director |
SELL
Open market or private sale
|
Direct |
359
-6.77%
|
$24,771
$69.19 P/Share
|
|
Sep 02
2021
|
Fred Hite COO and CFO |
SELL
Open market or private sale
|
Direct |
5,000
-7.06%
|
$355,000
$71.5 P/Share
|
|
Aug 31
2021
|
Stephen F Burns Director |
SELL
Open market or private sale
|
Indirect |
2,445
-25.89%
|
$163,815
$67.58 P/Share
|
|
Aug 27
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
807
+34.85%
|
$51,648
$64.85 P/Share
|
|
Aug 27
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
400
+3.88%
|
$25,600
$64.55 P/Share
|
|
Aug 27
2021
|
Stephen F Burns Director |
SELL
Open market or private sale
|
Indirect |
1,000
-9.57%
|
$65,000
$65.14 P/Share
|
|
Aug 24
2021
|
Stephen F Burns Director |
SELL
Open market or private sale
|
Indirect |
417
-3.84%
|
$27,105
$65.0 P/Share
|
|
Aug 10
2021
|
Bernie B Berry Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,340
+2.66%
|
$40,200
$30.97 P/Share
|
|
Aug 09
2021
|
Bernie B Berry Iii Director |
SELL
Open market or private sale
|
Direct |
100
-0.42%
|
$7,200
$72.0 P/Share
|
|
Aug 03
2021
|
Mark C Throdahl Director |
SELL
Open market or private sale
|
Direct |
4,774
-3.5%
|
$310,310
$65.4 P/Share
|
|
Aug 02
2021
|
Gregory A Odle President of Scoliosis |
BUY
Exercise of conversion of derivative security
|
Direct |
402
+0.6%
|
$12,060
$30.97 P/Share
|
|
Aug 02
2021
|
Mark C Throdahl Director |
SELL
Open market or private sale
|
Direct |
15,226
-10.03%
|
$989,690
$65.88 P/Share
|
|
Aug 02
2021
|
Bernie B Berry Iii Director |
SELL
Open market or private sale
|
Direct |
2,000
-7.82%
|
$132,000
$66.6 P/Share
|
|
Jul 20
2021
|
Terry D Schlotterback Director |
BUY
Exercise of conversion of derivative security
|
Direct |
670
+4.58%
|
$20,100
$30.97 P/Share
|
|
Jun 15
2021
|
Bernie B Berry Iii Director |
SELL
Open market or private sale
|
Direct |
300
-1.16%
|
$19,200
$64.54 P/Share
|
|
Jun 02
2021
|
Terry D Schlotterback Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+9.53%
|
-
|
|
Jun 02
2021
|
Samuel D Riccitelli Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+20.0%
|
-
|
|
Jun 02
2021
|
Harold Ruf Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+50.0%
|
-
|
|
Jun 02
2021
|
David R Pelizzon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+5.91%
|
-
|
|
Jun 02
2021
|
Bryan W Hughes Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+17.94%
|
-
|
|
Jun 02
2021
|
(Reynolds) Marie C Infante Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+20.89%
|
-
|
|
Jun 02
2021
|
Stephen F Burns Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+20.0%
|
-
|
|
Jun 02
2021
|
Kevin Unger Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+20.0%
|
-
|
|
Jun 02
2021
|
Bernie B Berry Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,400
+5.13%
|
-
|
|
May 13
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,500
+50.0%
|
$84,000
$56.05 P/Share
|
|
May 13
2021
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,500
+13.64%
|
$85,500
$57.49 P/Share
|
|
May 10
2021
|
Terry D Schlotterback Director |
SELL
Open market or private sale
|
Indirect |
4,700
-64.86%
|
$296,100
$63.03 P/Share
|
|
May 10
2021
|
Daniel J Gerritzen General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
4,000
-11.51%
|
$252,000
$63.03 P/Share
|
|
May 06
2021
|
Bernie B Berry Iii Director |
SELL
Open market or private sale
|
Direct |
3,209
-11.59%
|
$192,540
$60.0 P/Share
|
|
May 03
2021
|
Bernie B Berry Iii Director |
SELL
Open market or private sale
|
Direct |
4,791
-14.75%
|
$287,460
$60.15 P/Share
|
|
May 03
2021
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
3,750
-5.34%
|
$225,000
$60.2 P/Share
|
|
Mar 16
2021
|
(Reynolds) Marie C Infante Director |
SELL
Open market or private sale
|
Direct |
700
-15.21%
|
$31,500
$45.78 P/Share
|
|
Mar 15
2021
|
Harold Ruf Director |
BUY
Other acquisition or disposition
|
Indirect |
2,400
+50.0%
|
-
|
|
Mar 15
2021
|
Harold Ruf Director |
SELL
Other acquisition or disposition
|
Indirect |
2,400
-12.71%
|
-
|
|
Mar 15
2021
|
Harold Ruf Director |
BUY
Open market or private purchase
|
Indirect |
2,880
+13.42%
|
$132,480
$46.98 P/Share
|
|
Mar 15
2021
|
David R Pelizzon Director |
BUY
Open market or private purchase
|
Direct |
3,700
+15.04%
|
$170,200
$46.5 P/Share
|
|
Mar 02
2021
|
David R Bailey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,119
+6.94%
|
-
|
|
Mar 02
2021
|
Mark C Throdahl Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,277
+3.36%
|
-
|
|
Mar 02
2021
|
Gregory A Odle President of Scoliosis |
BUY
Grant, award, or other acquisition
|
Direct |
5,929
+7.79%
|
-
|
|
Mar 02
2021
|
Fred Hite COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,119
+9.14%
|
-
|
|
Mar 02
2021
|
Daniel J Gerritzen General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
5,756
+14.21%
|
-
|
|
Mar 01
2021
|
David R Bailey President and CEO |
SELL
Open market or private sale
|
Direct |
4,769
-5.12%
|
$262,295
$55.84 P/Share
|
|
Mar 01
2021
|
Mark C Throdahl Director |
SELL
Open market or private sale
|
Direct |
5,097
-3.36%
|
$280,335
$55.88 P/Share
|
|
Mar 01
2021
|
Gregory A Odle President of Scoliosis |
SELL
Open market or private sale
|
Direct |
8,193
-11.3%
|
$450,615
$55.88 P/Share
|
|
Mar 01
2021
|
Fred Hite COO and CFO |
SELL
Open market or private sale
|
Direct |
4,310
-6.34%
|
$237,050
$55.87 P/Share
|
|
Mar 01
2021
|
Daniel J Gerritzen General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,633
-8.32%
|
$144,815
$55.85 P/Share
|
|
Feb 25
2021
|
Bernie B Berry Iii Director |
SELL
Open market or private sale
|
Direct |
699
-2.11%
|
$39,843
$57.0 P/Share
|
|
Feb 22
2021
|
Bernie B Berry Iii Director |
SELL
Open market or private sale
|
Direct |
1,600
-4.6%
|
$91,200
$57.09 P/Share
|